SIBN · NASDAQ
SI-BONE, Inc.
$22.41 +0.60 (+2.75%)
Company overview
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $1B
- Employees
- 349
- Headquarters
- Santa Clara, CA
- Website
- si-bone.com
- CEO
- Laura A. Francis
- Listed
- October 17, 2018
- P/E
- -57.77
- Dividend yield
- 0.00%
Company financials
- Revenue
- $206M
- Gross profit
- $164M
- Operating income
- -$19.9M
- EBITDA
- -$7.3M
- Net income
- -$16.7M
- EPS
- -$0.39
- Total assets
- $243M
- Total debt
- $7.3M
- Gross margin
- 79.59%
- Net margin
- -8.10%
- Earnings yield
- -1.73%
No product segmentation.
Showing FY 2025
SIBN
1D
NASDAQ
O21.32H21.96L21.32C21.83+0.39 (+1.82%)Vol452.49K